Measles cases surge worldwide, access to vaccine is ‘inadequate’: WHO
Measles cases worldwide have risen 20% year-on-year in 2023 to about 10.3 million due to inadequate access to vaccines, according to new estimates.
Drugs
Health
Pharma
Drugs
Health
Pharma
Vaccines against pathogens can cut global antibiotic usage by 22%
Vaccines against 24 pathogens could cut the number of antibiotics needed to fight antimicrobial resistance by 2.5 billion daily doses or 22% globally,.
Drugs
Health
Pharma
GSK’s vaccine for severe RSV shows 43.3% effectiveness in third year
GSK Plc.’s single dose respiratory syncytial virus (RSV) vaccine for a severe form of the disease proved 43.3% effective in the third season.
Drugs
Health
Pharma
WHO reports new case of MERS-CoV in Saudi Arabia, risk ‘moderate’
The WHO has been notified of a human case of Middle East Respiratory coronavirus (MERS-CoV) in the Kingdom of Saudi Arabia.
Drugs
Health
Pharma
‘Strong neutralizing responses’ shown in RSV vaccine trials: Pfizer says
Pfizer Inc.’s vaccine trials on patients aged 18 and older with chronic respiratory diseases show a consistent safety profile and “strong neutralizing responses,”.
Drugs
Health
Pharma
Merck’s vaccine for pneumococcal disease gets FDA’s green light
The US Food and Drug Administration has given the green light to Merck’s vaccine to protect adults against the different types of bacteria.
Drugs
Health
Pharma
Genetic factors may help predict loss of X chromosome in older women
Researchers co-led by the US-based National Cancer Institute have found genetic variants in women that may play a role in promoting abnormal blood.
Drugs
Health
Pharma
EC marketing nod for Pfizer drug to fight antimicrobial resistance
HQ Team April 22, 2024: The European Commission has granted Pfizer Inc., marketing authorisation for a drug to treat adult patients with intra-abdominal.
Drugs
Health
Pharma
US doctors still prescribe old generic antibiotics, cost main factor
HQ Team April 20, 2024: A bacteria that causes infections, including pneumonia, bloodstream infections, and meningitis are being treated by doctors with less.
Drugs
Health
Pharma
Swiss-based Basilea Pharmaceutical’s antimicrobial drug gets FDA nod
HQ Team April 4, 2024: The USFDA approved Swiss-based Basilea Pharmaceutica International’s Zevtera injection for the treatment of staphylococcus aureus bloodstream infections and.